Maplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4

• Maplight Therapeutics director Troy Cox reported buying 15,620 shares of voting common stock at a weighted average price of $9.52.
• The shares were held indirectly through a trust, lifting his trust-held stake to 15,620 shares.
• Cox also reported 7,864 shares held directly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001696923-26-000007), on July 28, 2026, and is solely responsible for the information contained therein.